Stem cell treatment for SCA3 balance problems
Part of Brain & nervous system, Genetic & congenital clinical trials.
This trial tests an experimental stem cell treatment for people with SCA3, a genetic condition that affects balance and coordination. The goal is to see if the treatment can help improve or slow down these symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of SCA3 (spinocerebellar ataxia type 3) from a genetic test.
- Your balance and coordination score (SARA) should be between 5 and 15, which is mild to moderate difficulty.
- You must be between 20 and 70 years old.
- If you are a woman who could become pregnant, you need to be post-menopausal, or use effective birth control, and not be pregnant.
- Men must use a medically acceptable form of birth control during the study.
- You should not have had any stem cell therapy, chemotherapy, or radiation in the past few years, and no history of cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a non-invasive brain stimulation treatment (called cerebellar transcranial magnetic stimulation) can help improve balance and coordination in people with spinocerebellar ataxia. It may offer a new way to ease symptoms without surgery.
This study tests whether cycling-based coordination training can help people with spinocerebellar ataxia (SCA) improve balance and movement by priming the brain for recovery.
This study tests a single injection of umbilical cord stem cells for adults with spinocerebellar ataxia, a condition that affects balance and coordination. The goal is to see if it can slow down or improve symptoms.
This study tests a brain pacemaker (called deep brain stimulation) placed in the cerebellum to help improve balance and coordination in people with SCA1 or SCA3. It aims to see if this treatment can reduce ataxia symptoms and improve daily function.
This trial tests a non-invasive brain stimulation method to see if it can improve movement and balance in people with spinocerebellar ataxia type 3. It aims to find the best settings for this treatment.
This study tests a new treatment using special cells (stem cells) and their tiny particles (exosomes) to see if they are safe and help improve symptoms. It is for people with spinocerebellar ataxia, a condition that affects movement and coordination.
Hear when a new Spinocerebellar Ataxias trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.